Citation Impact
Citing Papers
B cell depletion reduces the development of atherosclerosis in mice
2010
Infection, inflammation, height, and longevity
2005 Standout
IFN- γ Deficiency Exerts Gender-Specific Effects on Atherogenesis in Apolipoprotein E -/- Mice
2002
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
Heparin-Protein Interactions
2002 Standout
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
CD44: From adhesion molecules to signalling regulators
2003 Standout
Inflammation and metabolic disorders
2006 StandoutNature
Flt3 Signaling-Dependent Dendritic Cells Protect against Atherosclerosis
2011 StandoutNobel
Apo A-I inhibits foam cell formation in apo E–deficient mice after monocyte adherence to endothelium
1999
Atherosclerosis: humoral and cellular factors of inflammation
2005
Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice.
1998
Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL
2003
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Signal integration by JNK and p38 MAPK pathways in cancer development
2009 Standout
Immunological responses to oxidized LDL
2000
Innate and acquired immunity in atherogenesis
2002
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Adaptive immunity in atherogenesis: new insights and therapeutic approaches
2013
Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the development of atherosclerosis
2000
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
2006
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
2021 Standout
Loss of Lymphotoxin-α but Not Tumor Necrosis Factor-α Reduces Atherosclerosis in Mice
2002
Vaccination against atherosclerosis? Induction of atheroprotective immunity
2009
MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment
2007 Standout
The changing landscape of atherosclerosis
2021 StandoutNature
Atherosclerosis: current pathogenesis and therapeutic options
2011 Standout
Inflammation, stress, and diabetes
2005 Standout
Atherothrombosis and High-Risk Plaque
2005
Engineering interferons and interleukins for cancer immunotherapy
2022
Disruption of TGF-β signaling in T cells accelerates atherosclerosis
2003
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
The immune system in atherosclerosis
2011 Standout
The immunology of atherosclerosis
2017
The macrophage foam cell as a target for therapeutic intervention
2002
Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E–deficient mice
2000 Standout
Interleukin-4 Does Not Influence Development of Hypercholesterolemia or Angiotensin II-Induced Atherosclerotic Lesions in Mice
2007
Chronic Angiotensin II Infusion Promotes Atherogenesis in Low Density Lipoprotein Receptor −/− Mice
1999
Adaptive immunity and atherosclerosis
2009
The immune response in atherosclerosis: a double-edged sword
2006 Standout
The adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular cell activation
2001
Apolipoprotein E and atherosclerosis: insight from animal and human studies
1999
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
2012 Standout
Inflammation in atherosclerosis
2016
α-Difluoromethylornithine suppresses inflammatory arthritis by impairing myeloid-derived suppressor cells
2019
Atherosclerosis — An Inflammatory Disease
1999 Standout
Inflammation in atherosclerosis
2002 StandoutNature
Origin and physiological roles of inflammation
2008 StandoutNature
Up-Regulated Expression of the CXCR2 Ligand KC/GRO-α in Atherosclerotic Lesions Plays a Central Role in Macrophage Accumulation and Lesion Progression
2006
CCR5 deficiency is not protective in the early stages of atherogenesis in apoE knockout mice
2003
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Exogenous Interferon-γ Enhances Atherosclerosis in Apolipoprotein E−/− Mice
2000
Protective and pathogenic functions of macrophage subsets
2011 Standout
Inflammation in Atherosclerosis
2009 Standout
A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice.
1998
Inflammation, Atherosclerosis, and Coronary Artery Disease
2005 Standout
Atherosclerosis
2000 StandoutNature
Deciphering the Roles of Innate Lymphoid Cells in Cancer
2019
Combined Serum Paraoxonase Knockout/Apolipoprotein E Knockout Mice Exhibit Increased Lipoprotein Oxidation and Atherosclerosis
2000 Standout
Atherosclerosis
2001 Standout
Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.
1998 Standout
Exploring the full spectrum of macrophage activation
2008 Standout
The pathogenesis of atherosclerosis: a perspective for the 1990s
1993 StandoutNature
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Sidestream cigarette smoke accelerates atherogenesis in apolipoprotein E−/− mice
2001
The Many Roles of Chemokines and Chemokine Receptors in Inflammation
2006 Standout
The Role of Interleukin-4 and Interleukin-12 in the Progression of Atherosclerosis in Apolipoprotein E-Deficient Mice
2003
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
Interleukin-10 Blocks Atherosclerotic Events In Vitro and In Vivo
1999
Genetic Background Determines the Extent of Atherosclerosis in ApoE-Deficient Mice
1999
Adipose Tissue, Inflammation, and Cardiovascular Disease
2005 Standout
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Adaptive Response of T and B Cells in Atherosclerosis
2016
Inflammation in Atherosclerosis
2012 Standout
Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy
2018
Mechanisms of Plaque Formation and Rupture
2014 Standout
Lanthanum Chloride Inhibits LPS Mediated Expressions of Pro-Inflammatory Cytokines and Adhesion Molecules in HUVECs: Involvement of NF-κB-Jmjd3 Signaling
2017 Standout
Macrophage-specific expression of class A scavenger receptors in LDL receptor−/− mice decreases atherosclerosis and changes spleen morphology
2002
Genetic Modifiers of Atherosclerosis in Mice
2000
Interleukin-18 Enhances Atherosclerosis in Apolipoprotein E −/− Mice Through Release of Interferon-γ
2002
B-Lymphocyte Deficiency Increases Atherosclerosis in LDL Receptor–Null Mice
2002
mTOR inhibitor INK128 attenuates dextran sodium sulfate‐induced colitis by promotion of MDSCs on Treg cell expansion
2018
Innate and Adaptive Immunity in the Pathogenesis of Atherosclerosis
2002
Interleukin-17–Dependent Autoimmunity to Collagen Type V in Atherosclerosis
2010
Requirement of JNK2 for Scavenger Receptor A-Mediated Foam Cell Formation in Atherogenesis
2004 Science
CD137 (4–1BB) Deficiency Reduces Atherosclerosis in Hyperlipidemic Mice
2010
The Role of Interleukin 12 in the Development of Atherosclerosis in ApoE-Deficient Mice
1999
Chemokine CXCL10 Promotes Atherogenesis by Modulating the Local Balance of Effector and Regulatory T Cells
2006
TRANSFORMING GROWTH FACTOR-β REGULATION OF IMMUNE RESPONSES
2005 Standout
Depletion of Natural Killer Cell Function Decreases Atherosclerosis in Low-Density Lipoprotein Receptor Null Mice
2004
Lessons From Sudden Coronary Death
2000 Standout
Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis
2016 Standout
Are Immunological Mechanisms Relevant for the Development of Atherosclerosis?
1999
The adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular cell activation
2001
Interleukin-4 Deficiency Decreases Atherosclerotic Lesion Formation in a Site-Specific Manner in Female LDL Receptor−/− Mice
2002
Immune mechanisms in atherosclerosis.
1989
Immune Mechanisms in Atherosclerosis
2001
Complete Atherosclerosis Regression After Human ApoE Gene Transfer in ApoE-Deficient/Nude Mice
2000
Effect of Immune Deficiency on Lipoproteins and Atherosclerosis in Male Apolipoprotein E–Deficient Mice
2001
Antiinflammatory Properties of HDL
2004 Standout
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Autoimmune and Inflammatory Mechanisms in Atherosclerosis
2004
INFLAMMATION AND ATHEROSCLEROSIS
2006
JNK1 controls mast cell degranulation and IL-1β production in inflammatory arthritis
2010 StandoutNobel
Immunization of LDL Receptor–Deficient Mice With Homologous Malondialdehyde-Modified and Native LDL Reduces Progression of Atherosclerosis by Mechanisms Other Than Induction of High Titers of Antibodies to Oxidative Neoepitopes
1998
Works of Siqi Chen being referenced
Host miR155 Promotes Tumor Growth through a Myeloid-Derived Suppressor Cell–Dependent Mechanism
2014
The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice.
1997
Graft-versus-Host Disease Is Enhanced by Selective CD73 Blockade in Mice
2013
A targeted IL-15 fusion protein with potent anti-tumor activity
2015
Type 2 Innate Lymphoid Cells Impede IL-33–Mediated Tumor Suppression
2018
Targeting Ornithine Decarboxylase by α-Difluoromethylornithine Inhibits Tumor Growth by Impairing Myeloid-Derived Suppressor Cells
2015